Biomet vet Serbousek to succeed Mason as Orthofix CEO

Biomet vet Serbousek to succeed Mason as Orthofix CEO | Personnel Moves, August 13, 2019

Orthofix (NSDQ:OFIX) last week named a successor for president & CEO Brad Mason in November, tapping Jon Serbousek as president of its spine business effective August 5.

Mason is slated to retire Oct. 31; Serbousek, a 30-year medtech veteran with stints at BiometMedtronic (NYSE:MDT) and Johnson & Johnson (NYSE:JNJ) unit DePuy Orthopaedics, is due to take over the corner office the next day.

“Jon’s expertise and proven track record are perfectly aligned with our business composition and make him an exceptional choice to lead the company as President and CEO,” Mason said in prepared remarks. “With the recent leadership change in our spine business, I am pleased that Jon has agreed to serve as the president of global spine on an interim basis. This will give him time to focus on our needs and opportunities in that business before he takes on the broader CEO role, which should help ensure a seamless leadership transition for the benefit of all Orthofix stakeholders.”

“I am excited to join Orthofix,” Serbousek added. “It is an honor to assume this leadership role, particularly at a time when the company is so well positioned for future shareholder value creation. I look forward to working with the great team at Orthofix as we continue to shape the company for the years ahead.”

Original Article: (

Written by